| An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Loxtra Eye Drops Containing Ofloxacin (3 mg), Prednisolone (2 mg) and Tetrahydrozoline Hydrochloride (0.4 mg) in Subjects with Bacterial Conjunctivitis and Other Ocular Inflammatory Conditions |
Completed |
Loxtra |
4 |
LOX001 |
King Khalid University Hospital (Riyadh) |
| An open label, Phase IV Multicentric Single Arm Study to Assess the Safety and Efficacy of Croma Ophthalmic Solution Containing Sodium Cromoglycate (40 mg/ml) and Tetrahydrozoline Hydrochloride (0.5 mg/ml) in Subjects with Chronic Allergic Conjunctivitis and Hay Fever (Seasonal) |
Completed |
Croma |
4 |
CROMA001 |
King Khalid University Hospital (Riyadh) |
| An Open Label, Phase IV, Multi-Centric, Prospective, Single Arm Study to Assess the Safety and Efficacy of Fluca Eye Drops Containing Sodium Cromoglycate (20 mg/ml) and Fluorometholone (1 mg/ml) in Subjects with Chronic Allergic Conjunctivitis and Hay Fever |
Completed |
FLUCA |
4 |
FLUCA001 |
King Khalid University Hospital (Riyadh) |
| The Effect of Sulfad tablet on Hepatitis B & C, achieving a sustained response |
Completed |
Sulfad |
3 |
Protocol dated: 2011 |
Northren Area Armed Force Hospital |
| Alleviating Post Surgical Dental Pain |
Rejected |
Profinal XP 400 mg F.C Tablet |
4 |
1/2010/PXP/JUL |
N/A |
| A 26-week, Randomized, Double-blinded, Placebo controlled study to explore the Effects of Probiotics on Endotoxin Levels in patients with Type 2 Diabetes Mellitus |
Completed |
Probiotics |
3 |
STRP-10 |
King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Riyadh), Minstery of Health |
| "A prospective, observational, non-randomized, European, multi-centerregistry, collecting REal-life information for the utilization of instantaneouswave-free ratio™ (iFR®) in Assessing coronary stenosis relevance in theMulti-vesseL disease patients population." |
Rejected |
VOLCAO-iFR® |
4 |
2014-CV-00 |
N/A |
| "Prospective Observational Clinical Practice Study in the 1st LineManagement of mCRC with Erbitux ™ in combination with Chemotherapy" |
Rejected |
ERBITUX |
4 |
EMR062202_ |
N/A |
A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men who are at High Risk for Poor Clinical Outcomes after Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men with Castration-Resistant Prostate Cancer and Men with Metastatic Prostate Cancer at Initial Diagnosis
|
Rejected |
|
|
ONC-MA1001
|
N/A |
| RETROSPECTIVE EPIDEMIOLOGY STUDY OF ALK REARRANGEMENT IN NON-SMALL CELL LUNG CANCER PATIENTS IN THE MIDDLE EAST & NORTH AFRICA |
Rejected |
- |
4 |
A8081046 |
N/A |
